News

The World Health Organization has identified air pollution as the leading environmental health risk globally, responsible for 4.2 million deaths

In the modern era, concern for health and the prevention of non-communicable diseases has reached alarming proportions. With MetBalance test

In the following 3 years, Biosfer Teslab will be coordinating a consortium of companies and research centers in the framework

The Marató de TV3 has announced that the upcoming edition, scheduled for December 17, 2023, will focus on Sexual and

Nuclear Magnetic Resonance (NMR) metabolomics emerges as a promising tool in HIV research due to its ability to provide a

In an effort to contribute to the fight against cancer, Biosfer Teslab has actively participated in ‘Lliga’t a la Vida’.

Cardiovascular events occur despite the control of conventional risk factors. Inflammation plays numerous roles in the pathogenesis of atherosclerotic cardiovascular

Metabolomic profiling involves identifying intermediary molecules and end-products of metabolism, encompassing lipids, lipoproteins, fatty acid variants, amino acids, and glycoprotein

On Monday, October 16, 2023, our CEO Núria Amigó participated in the event “Empowering the Future We Want” alongside Jose

Lipoproteins are much more than just vehicles for cholesterol in our body. Although lipid analysis has traditionally focused on measuring

Cardiovascular disease (CVD) claims the lives of over 4 million people in Europe every year. Dyslipidemia, a disorder characterized by

NMR metabolomics & AI in neonatal health Did you know that there are almost 3 million fetal and neonatal deaths every